Search Results - "浜見, 学"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    泌尿器科領域におけるKW-1070の基礎的・臨床的検討 by 藤井, 昭男, 浜見, , 荒川, 創一, 彦坂, 幸治, 守殿, 貞夫, 石神, 襄次, 伊藤, 登, 斎藤, 博, 中野, 康治

    Published in CHEMOTHERAPY (1981)
    “…新アミノ配糖体系抗生物質KW-1070について基礎的・臨床的検討を行なった。 抗菌力については, 尿路由来の臨床分離株に対しGM, AMKおよびnetilmicinと比較した。E. coli, Klebsiella, Enterobacter, P. mirabilisおよびindole陽性Proteusでは,…”
    Get full text
    Journal Article
  3. 3

    複雑性尿路感染症に対するNetilmicinの基礎と臨床 by 藤井, 昭男, 浜見, , 中野, 康治, 杉本, 正行, 梅津, 敬一, 荒川, 創一, 守殿, 貞夫, 石神, 襄次

    Published in CHEMOTHERAPY (1981)
    “…新アミノグリコシド系抗生物質Netilmicinについて基礎的・臨床的検討を行なった。 抗菌力に関しては, 当科入院患者の尿路感染症より分離した菌株について本剤とGentamicin (GM) およびAmikacin (AMK) の抗菌力を比較した。108/ml接種では,…”
    Get full text
    Journal Article
  4. 4

    泌尿器科領域におけるCefadroxilの基礎と臨床 by 彦坂, 幸治, 浜見, , 山中, 望, 黒田, 泰二, 守殿, 貞夫, 石神, 襄次

    Published in CHEMOTHERAPY (1980)
    “…Cefadroxilにつき基礎的ならびに臨床的検討を行なった結果は, 次のとおりである. 1.抗菌力:各種尿路感染症分離株に対するCefadroxilおよびCephalexinのMICを比較検討(接種菌量:108cells/ml)したところ, S. epidermidis, K. pneumoniaeでは,…”
    Get full text
    Journal Article
  5. 5

    FUNDAMENTAL AND CLINICAL STUDIES WITH SISOMICIN IN UROLOGY by TAKAHASHI, YASUMASA, HAMAMI, MANABU, TOMIOKA, OSAMU, ISHIGAMI, JOJI

    Published in CHEMOTHERAPY (25-07-1978)
    “…1. Antibacterial activity Minimum inhibitory concentrations of Sisomicin and GM were measured on Pseudomonas aeruginosa (27strains) and Serratia marcescens (83…”
    Get full text
    Journal Article
  6. 6

    FUNDAMENTAL AND CLINICAL EVALUATION OF KW-1070 IN THE FIELD OF UROLOGY by FUJII, TERUO, HAMAMI, MANABU, ARAKAWA, SOICHI, HIKOSAKA, KOJI, KAMIDONO, SADAO, ISHIGAMI, JOJI, ITO, NOBUO, ITO, HIROSHI, NAKANO, YASUHARU

    Published in CHEMOTHERAPY (25-10-1981)
    “…KW-1070, a new aminoglycoside antibiotic, was studied fundamentally and clinically. Antibacterial effects of KW-1070 against clinical isolates derived from…”
    Get full text
    Journal Article
  7. 7

    Vesicocolic fistula formed by "collision" tumor between transitional cell carcinoma of urinary bladder and adenocarcinoma of the sigmoid colon by Oda, Y, Hamami, G, Umezu, K, Sugimoto, M, Yasumuro, C, Fujii, A, Kamidono, S, Ishigami, J

    Published in Hinyokika kiyo. Acta urologica Japonica (01-01-1984)
    “…A patient with vesicosigmoid fistula due to "collision" tumor between adenocarcinoma of the sigmoid colon and transitional cell carcinoma of the urinary…”
    Get full text
    Journal Article
  8. 8

    BASIC AND CLINICAL EFFECTS OF NETILMICIN ON COMPLICATED URINARY TRACT INFECTIONS by FUJII, AKIO, HAMAMI, GAKU, NAKANO, YASUHARU, SUGIMOTO, MASAYUKI, UMEZU, KEIICHI, ARAKAWA, SOICHI, KAMIDONO, SADAO, ISHIGAMI, JOJI

    Published in CHEMOTHERAPY (1981)
    “…Basic and clinical effects of Netilmicin, a new aminoglycoside antibiotic were examined. Against clinical isolates from the patients with urinary tract…”
    Get full text
    Journal Article
  9. 9

    EXPERIMENTAL AND CLINICAL STUDIES OF CEFADROXIL IN THE FIELD OF UROLOGY by HIKOSAKA, KOZI, HAMAMI, GAKU, YAMANAKA, Nozomu, KURODA, YASUZI, KAMIDONO, SADAO, ISHIGAMI, JOJI

    Published in CHEMOTHERAPY (1980)
    “…1. Antibacterial activity Minimum inhibitory concentrations (MICs) of cefadroxil were measured at inoculum size of 108cells/ml against the strains isolated…”
    Get full text
    Journal Article
  10. 10

    BASIC AND CLINICAL STUDIES ON CEFETAMET PIVOXIL IN UROLOGY by KO, ZHAO-REN, KUWAYAMA, MASAYUKI, YAMASHITA, MASUO, ARAKAWA, SOICHI, MATSUMOTO, OSAMU, KAMIDOMO, SADAO, KATAOKA, NOBUTOSH, UMEZU, KEIICHI, TOMIOKA, OSAMU, FUJII, AKIRA, HIROOKA, KUHEI, YASUMURO, CHOZO, HAMAMI, GAKU, OHSIMA, HIDEO

    Published in CHEMOTHERAPY (1990)
    “…We basically and clinically evaluated cefetamet pivoxil, a new oral cephalosporin, in the urological field. 1) The in vitro antimicrobial activity of cefetamet…”
    Get full text
    Journal Article
  11. 11

    泌尿器科領域におけるcefetamet pivoxilの基礎的および臨床的検討 by 柯, 昭仁, 桑山, 雅行, 山下, 真寿男, 荒川, 創一, 松本, 修, 守殿, 貞夫, 片岡, 陳正, 梅津, 敬一, 富岡, 収, 藤井, 明, 広岡, 九兵衛, 安室, 朝三, 濱見, , 大島, 秀夫

    Published in CHEMOTHERAPY (1990)
    “…新しく開発された経口用セフェム系抗生剤cefetamet pivoxil (CEMT-PI) の基礎的および臨床的検討を行い以下の結果を得た。 1) 抗菌力: 尿路感染症分離グラム陽性菌2菌種およびグラム陰性菌8菌種に対する本剤およびcefteram (CFTM), cefixime (CFIX), cefaclor…”
    Get full text
    Journal Article